Immunization and Maternal Child Health Programs: Ideas for Partnering to Protect Women and Children
Explore AIM’s one-pager about collaboration opportunities between immunization programs (IPs) and maternal child health (MCH) programs.
VAC Beaches Profiles
As part of the Vaccine Access Cooperative (VAC) project, this collection of jurisdiction profiles details AIM’s Beaches region.
The Power of Cultural Validation – Frontier and Beaches VAC Presentation
At the Frontier and Beaches VAC meetings, Julissa Soto, an independent health equity consultant, presented on the power of cultural validation for immigrants and refugees.
Adolescent Immunization Toolkit
On July 9, 2025, the U.S. Food and Drug Administration (FDA) released its decision to approve the supplemental Biologics License Application (BLA) for SPIKEVAX, but only for use in individuals…
FDA Gives Approval to Moderna’s Spikevax COVID-19 Vaccine for Children 6 Months Through 11 years… But Only If at High Risk
On July 9, 2025, the FDA released its decision to approve the supplemental Biologics License Application (BLA) for SPIKEVAX, but only for certain ages at high risk.
mRNA Vaccines Are Here to Stay: Debunking Myths and False Information
This blog entry provides an overview of the history and future of mRNA vaccines.
Reminder/Recall Program
AIM's reminder/recall (RR) program aims to increase immunization rates by assisting members in designing and coordinating reminder/recall postcard mailings.
Engaging Community Leaders in Household Reminder Postcard Campaigns-2023 AIRA National Meeting Presentation
AIM partnered with CHWs in five states to develop and implement COVID-19 household reminder postcard campaigns with messaging developed by trusted leaders.
Request for Interest Forms: Community of Practice to Optimize Administration of Birth Dose Immunizations
AIM invites participation in its Immunization Program and Birthing Institution Community of Practice (CoP) to Optimize Administration of Birth Dose Immunizations.
What’s Happening with Aluminum?
Likely you’ve heard some back-and-forth recently about the use of aluminum as an adjuvant in vaccines. Here’s what you need to know from both sides of the argument.